RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,687 | +8.6% | 115,229 | -11.0% | 0.00% | – |
| Q2 2023 | $318,395 | -74.4% | 129,429 | -76.5% | 0.00% | – |
| Q1 2023 | $1,245,477 | -64.0% | 551,096 | -44.4% | 0.00% | – |
| Q4 2022 | $3,460,216 | -84.2% | 991,466 | +68.0% | 0.00% | -100.0% |
| Q3 2022 | $21,847,000 | +91.4% | 590,134 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $11,417,000 | -5.1% | 601,185 | +34.9% | 0.00% | 0.0% |
| Q1 2022 | $12,026,000 | +65.1% | 445,564 | +37.8% | 0.00% | – |
| Q4 2021 | $7,286,000 | -14.7% | 323,401 | -0.8% | 0.00% | – |
| Q3 2021 | $8,541,000 | -14.0% | 325,871 | +5.1% | 0.00% | -100.0% |
| Q2 2021 | $9,928,000 | -3.0% | 310,164 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $10,231,000 | +4.8% | 290,585 | -4.6% | 0.00% | 0.0% |
| Q4 2020 | $9,764,000 | -14.1% | 304,459 | +0.7% | 0.00% | 0.0% |
| Q3 2020 | $11,373,000 | -10.8% | 302,321 | +6.2% | 0.00% | 0.0% |
| Q2 2020 | $12,744,000 | +4340.4% | 284,771 | +3290.1% | 0.00% | – |
| Q1 2020 | $287,000 | – | 8,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |